Susquehanna International Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.03M | Sell |
20,221
-63,875
| -76% | -$29.8M | ﹤0.01% | 3275 |
|
|
2025
Q4 | $38.1M | Buy |
84,096
+16,413
| +24% | +$7.07M | ﹤0.01% | 1596 |
|
|
2025
Q3 | $26.5M | Buy |
67,683
+5,474
| +9% | +$2.29M | ﹤0.01% | 1906 |
|
|
2025
Q2 | $27.7M | Buy |
62,209
+21,088
| +51% | +$9.72M | ﹤0.01% | 1675 |
|
|
2025
Q1 | $19.9M | Sell |
41,121
-89,284
| -68% | -$41.6M | ﹤0.01% | 1745 |
|
|
2024
Q4 | $52.5M | Buy |
130,405
+84,357
| +183% | +$39.1M | 0.01% | 1084 |
|
|
2024
Q3 | $21.4M | Sell |
46,048
-33,530
| -42% | -$16.1M | ﹤0.01% | 1769 |
|
|
2024
Q2 | $37.3M | Sell |
79,578
-15,402
| -16% | -$6.69M | 0.01% | 1196 |
|
|
2024
Q1 | $39.7M | Sell |
94,980
-30,904
| -25% | -$13.1M | 0.01% | 1197 |
|
|
2023
Q4 | $51.2M | Sell |
125,884
-73,360
| -37% | -$27.1M | 0.01% | 1022 |
|
|
2023
Q3 | $69.3M | Buy |
199,244
+24,958
| +14% | +$8.73M | 0.01% | 809 |
|
|
2023
Q2 | $61.3M | Sell |
174,286
-71,067
| -29% | -$23.9M | 0.01% | 862 |
|
|
2023
Q1 | $77.3M | Sell |
245,353
-33,648
| -12% | -$10.1M | 0.02% | 714 |
|
|
2022
Q4 | $80.6M | Buy |
279,001
+232,658
| +502% | +$70.9M | 0.02% | 645 |
|
|
2022
Q3 | $13.4M | Sell |
46,343
-61,778
| -57% | -$17.8M | ﹤0.01% | 1823 |
|
|
2022
Q2 | $30.5M | Buy |
108,121
+5,268
| +5% | +$1.41M | 0.01% | 1145 |
|
|
2022
Q1 | $26.8M | Sell |
102,853
-233,472
| -69% | -$55.4M | ﹤0.01% | 1432 |
|
|
2021
Q4 | $73.9M | Sell |
336,325
-213,904
| -39% | -$41.6M | 0.01% | 872 |
|
|
2021
Q3 | $99.8M | Buy |
550,229
+46,682
| +9% | +$9.11M | 0.01% | 785 |
|
|
2021
Q2 | $102M | Buy |
503,547
+4,681
| +0.9% | +$979K | 0.01% | 777 |
|
|
2021
Q1 | $107M | Buy |
498,866
+247,146
| +98% | +$54.3M | 0.02% | 694 |
|
|
2020
Q4 | $59.5M | Buy |
251,720
+232,147
| +1,186% | +$53.3M | 0.01% | 909 |
|
|
2020
Q3 | $5.33M | Sell |
19,573
-128,739
| -87% | -$35.5M | ﹤0.01% | 2969 |
|
|
2020
Q2 | $43.1M | Buy |
148,312
+77,971
| +111% | +$21.1M | 0.01% | 909 |
|
|
2020
Q1 | $16.7M | Sell |
70,341
-47,364
| -40% | -$10.9M | 0.01% | 1307 |
|
|
2019
Q4 | $25.8M | Buy |
117,705
+115,618
| +5,540% | +$23.4M | 0.01% | 1210 |
|
|
2019
Q3 | $354K | Sell |
2,087
-12,383
| -86% | -$2.19M | ﹤0.01% | 7960 |
|
|
2019
Q2 | $2.65M | Buy |
14,470
+11,863
| +455% | +$2.07M | ﹤0.01% | 3659 |
|
|
2019
Q1 | $480K | Buy |
+2,607
| New | +$482K | ﹤0.01% | 6363 |
|
|
2018
Q3 | – | Sell |
-23,588
| Closed | -$4.2M | – | 10324 |
|
|
2018
Q2 | $4.01M | Buy |
23,588
+19,340
| +455% | +$3M | ﹤0.01% | 3005 |
|
|
2018
Q1 | $692K | Sell |
4,248
-121
| -3% | -$19.8K | ﹤0.01% | 5980 |
|
|
2017
Q4 | $655K | Sell |
4,369
-5,235
| -55% | -$775K | ﹤0.01% | 6094 |
|
|
2017
Q3 | $1.46M | Buy |
9,604
+3,512
| +58% | +$529K | ﹤0.01% | 4523 |
|
|
2017
Q2 | $785K | Sell |
6,092
-13,377
| -69% | -$1.61M | ﹤0.01% | 5775 |
|
|
2017
Q1 | $2.13M | Sell |
19,469
-13,620
| -41% | -$1.2M | ﹤0.01% | 3606 |
|
|
2016
Q4 | $2.44M | Buy |
+33,089
| New | +$2.69M | ﹤0.01% | 3656 |
|
|
2016
Q3 | – | Sell |
-2,460
| Closed | -$232K | – | 9121 |
|
|
2016
Q2 | $212K | Sell |
2,460
-54,199
| -96% | -$4.68M | ﹤0.01% | 7524 |
|
|
2016
Q1 | $4.5M | Sell |
56,659
-4,871
| -8% | -$441K | ﹤0.01% | 2439 |
|
|
2015
Q4 | $7.74M | Sell |
61,530
-99,952
| -62% | -$12.1M | ﹤0.01% | 2015 |
|
|
2015
Q3 | $16.8M | Buy |
161,482
+4,596
| +3% | +$590K | 0.01% | 1367 |
|
|
2015
Q2 | $19.4M | Buy |
156,886
+46,426
| +42% | +$5.85M | 0.01% | 1332 |
|
|
2015
Q1 | $13M | Sell |
110,460
-8,209
| -7% | -$984K | 0.01% | 1619 |
|
|
2014
Q4 | $14.1M | Sell |
118,669
-26,788
| -18% | -$3.02M | 0.01% | 1651 |
|
|
2014
Q3 | $16.3M | Sell |
145,457
-155,185
| -52% | -$14.8M | 0.01% | 1618 |
|
|
2014
Q2 | $28.5M | Buy |
300,642
+130,132
| +76% | +$9.13M | 0.01% | 1094 |
|
|
2014
Q1 | $12.1M | Sell |
170,510
-334,940
| -66% | -$26.5M | 0.01% | 1790 |
|
|
2013
Q4 | $37.6M | Buy |
505,450
+268,757
| +114% | +$18.7M | 0.02% | 838 |
|
|
2013
Q3 | $17.9M | Buy |
236,693
+46,535
| +24% | +$3.7M | 0.01% | 1305 |
|
|
2013
Q2 | $15.2M | Buy |
+190,158
| New | +$14M | 0.01% | 1369 |
|
Other funds holding VRTX
VCM
VPM
Susquehanna International Group's VRTX Position: Q1 2026 in Review
Susquehanna International Group reduced its Vertex Pharmaceuticals (VRTX) stake by 76% in Q1 2026, selling an estimated $29.8M and leaving 20,221 shares worth $9.03M. The position accounts for ﹤0.01% of the portfolio, ranked #3275.
Susquehanna International Group first reported a position in VRTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $107M in Q1 2021. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Susquehanna International Group held 20,221 shares of Vertex Pharmaceuticals worth $9.03M as of Q1 2026.
- Susquehanna International Group sold 63,875 Vertex Pharmaceuticals shares in Q1 2026, an estimated $29.8M.
- Vertex Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3275 holding.
- Susquehanna International Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- Susquehanna International Group's Vertex Pharmaceuticals position peaked at $107M in Q1 2021.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.